An Analytical Approach that Combines Knowledge from Germline and Somatic Mutations Enhances Tumor Genomic Reanalyses...

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Expanded tumor genomics analysis offers benefits in diagnosis, prognosis, and therapeutics.
• Expert analysis of tumor genomic data from 1146 patients was performed.

Purpose of the Study:

• To develop an analytical approach combining germline and cancer genetics knowledge.
• To evaluate the yield of medically relevant data from tumor genomics.
• To identify challenges and opportunities in variant interpretation.

Main Methods:

• Collected tumor genomic data from 1146 patients.
• Developed a novel analytical approach integrating germline and cancer genetics.
• Evaluated variants of uncertain significance (VUS) using combined genetic knowledge.

Main Results:

• Identified 499 cases (44%) with variants of interest (actionable or pathogenic).
• Reclassified 462 tumor variants (6.2%) from VUS to likely pathogenic using germline data.
• Found a significant proportion of reclassified variants (36%-79%) were previously reported in heritable disorders.

Conclusions:

• Highlights the need for improved data systems for variant annotation and interpretation.
• Demonstrates the multi-specialty value of integrated genomics data in precision oncology.
• Emphasizes the importance of sharing genomics data across medical specialties for robust patient care.